Matinas BioPharma Holdings, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for MTNB, updated each market day.
MTNB AI Sentiment
AI predicts Matinas BioPharma Holdings, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Sector
Exchange
Market Cap
$2,394,925
Cap Tier
Employees
2
Headquarters
BEDMINSTER, NJ
Listed Since
July 21, 2014
Website
MTNB Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MTNB Volatility
Matinas BioPharma Holdings, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
